These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. ICOS-dependent homeostasis and function of Foxp3+ regulatory T cells in islets of nonobese diabetic mice. Kornete M; Sgouroudis E; Piccirillo CA J Immunol; 2012 Feb; 188(3):1064-74. PubMed ID: 22227569 [TBL] [Abstract][Full Text] [Related]
4. Transient Depletion of Foxp3 Watts D; Janßen M; Jaykar M; Palmucci F; Weigelt M; Petzold C; Hommel A; Sparwasser T; Bonifacio E; Kretschmer K Front Immunol; 2021; 12():720133. PubMed ID: 34447385 [TBL] [Abstract][Full Text] [Related]
5. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy. Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973 [TBL] [Abstract][Full Text] [Related]
6. Ethyl Pyruvate Stimulates Regulatory T Cells and Ameliorates Type 1 Diabetes Development in Mice. Koprivica I; Vujičić M; Gajić D; Saksida T; Stojanović I Front Immunol; 2018; 9():3130. PubMed ID: 30687329 [TBL] [Abstract][Full Text] [Related]
7. Acceleration of diabetes development in CXC chemokine receptor 3 (CXCR3)-deficient NOD mice. Yamada Y; Okubo Y; Shimada A; Oikawa Y; Yamada S; Narumi S; Matsushima K; Itoh H Diabetologia; 2012 Aug; 55(8):2238-45. PubMed ID: 22487925 [TBL] [Abstract][Full Text] [Related]
8. Pancreatic β-Cell production of CXCR3 ligands precedes diabetes onset. Burke SJ; Karlstad MD; Eder AE; Regal KM; Lu D; Burk DH; Collier JJ Biofactors; 2016 Nov; 42(6):703-715. PubMed ID: 27325565 [TBL] [Abstract][Full Text] [Related]
9. CD4+ CD25+ regulatory T cells prevent type 1 diabetes preceded by dendritic cell-dominant invasive insulitis by affecting chemotaxis and local invasiveness of dendritic cells. Lee MH; Lee WH; Todorov I; Liu CP J Immunol; 2010 Aug; 185(4):2493-501. PubMed ID: 20639483 [TBL] [Abstract][Full Text] [Related]
10. Plasmacytoid dendritic cells license regulatory T cells, upon iNKT-cell stimulation, to prevent autoimmune diabetes. Beaudoin L; Diana J; Ghazarian L; Simoni Y; Boitard C; Lehuen A Eur J Immunol; 2014 May; 44(5):1454-66. PubMed ID: 24481989 [TBL] [Abstract][Full Text] [Related]
11. Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. Tarbell KV; Petit L; Zuo X; Toy P; Luo X; Mqadmi A; Yang H; Suthanthiran M; Mojsov S; Steinman RM J Exp Med; 2007 Jan; 204(1):191-201. PubMed ID: 17210729 [TBL] [Abstract][Full Text] [Related]
12. Generation of human Th1-like regulatory CD4+ T cells by an intrinsic IFN-γ- and T-bet-dependent pathway. Zheng J; Liu Y; Qin G; Lam KT; Guan J; Xiang Z; Lewis DB; Lau YL; Tu W Eur J Immunol; 2011 Jan; 41(1):128-39. PubMed ID: 21182084 [TBL] [Abstract][Full Text] [Related]
13. All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells. Van YH; Lee WH; Ortiz S; Lee MH; Qin HJ; Liu CP Diabetes; 2009 Jan; 58(1):146-55. PubMed ID: 18984738 [TBL] [Abstract][Full Text] [Related]
14. CD4(+) type II NKT cells mediate ICOS and programmed death-1-dependent regulation of type 1 diabetes. Kadri N; Korpos E; Gupta S; Briet C; Löfbom L; Yagita H; Lehuen A; Boitard C; Holmberg D; Sorokin L; Cardell SL J Immunol; 2012 Apr; 188(7):3138-49. PubMed ID: 22371394 [TBL] [Abstract][Full Text] [Related]
15. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice. Piccirillo CA; Tritt M; Sgouroudis E; Albanese A; Pyzik M; Hay V Ann N Y Acad Sci; 2005 Jun; 1051():72-87. PubMed ID: 16126946 [TBL] [Abstract][Full Text] [Related]
16. ICOS mediates the development of insulin-dependent diabetes mellitus in nonobese diabetic mice. Hawiger D; Tran E; Du W; Booth CJ; Wen L; Dong C; Flavell RA J Immunol; 2008 Mar; 180(5):3140-7. PubMed ID: 18292537 [TBL] [Abstract][Full Text] [Related]
17. Different modulation of Ptpn22 in effector and regulatory T cells leads to attenuation of autoimmune diabetes in transgenic nonobese diabetic mice. Yeh LT; Miaw SC; Lin MH; Chou FC; Shieh SJ; Chuang YP; Lin SH; Chang DM; Sytwu HK J Immunol; 2013 Jul; 191(2):594-607. PubMed ID: 23752610 [TBL] [Abstract][Full Text] [Related]
18. Berretta F; Piccirillo CA; Stevenson MM Front Immunol; 2019; 10():425. PubMed ID: 30915078 [TBL] [Abstract][Full Text] [Related]
19. Gut dysbiosis promotes islet-autoimmunity by increasing T-cell attraction in islets via CXCL10 chemokine. Pöysti S; Silojärvi S; Brodnicki TC; Catterall T; Liu X; Mackin L; Luster AD; Kay TWH; Christen U; Thomas HE; Hänninen A J Autoimmun; 2023 Nov; 140():103090. PubMed ID: 37572540 [TBL] [Abstract][Full Text] [Related]
20. Abrogation of ICOS/ICOS ligand costimulation in NOD mice results in autoimmune deviation toward the neuromuscular system. Prevot N; Briet C; Lassmann H; Tardivel I; Roy E; Morin J; Mak TW; Tafuri A; Boitard C Eur J Immunol; 2010 Aug; 40(8):2267-76. PubMed ID: 20544729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]